145 related articles for article (PubMed ID: 19388879)
1. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis.
Cho WC; Chen HY
Expert Opin Investig Drugs; 2009 May; 18(5):617-35. PubMed ID: 19388879
[TBL] [Abstract][Full Text] [Related]
2. Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population.
Jia S; Fu Y; Tao H
Pharm Biol; 2020 Dec; 58(1):771-784. PubMed ID: 32767901
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Yang M; Wu XN
Integr Cancer Ther; 2018 Jun; 17(2):477-485. PubMed ID: 29108428
[TBL] [Abstract][Full Text] [Related]
4. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of Jianpi Liqi Fang combined with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and spleen deficiency syndrome.
Chen X; Wang P; Yang M; Zhou W; Chen J; Meng Z; Su S
J Tradit Chin Med; 2021 Feb; 41(1):157-166. PubMed ID: 33522209
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of jiedu granules combined with cinobufacini injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial.
Chen Z; Chen HY; Lang QB; Li B; Zhai XF; Guo YY; Yue XQ; Ling CQ
Chin J Integr Med; 2012 May; 18(5):339-44. PubMed ID: 22549390
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma.
Zhang YQ; Zhao F; Song L; Gan HY; Xie XF
J Evid Based Complementary Altern Med; 2017 Oct; 22(4):883-891. PubMed ID: 29228810
[TBL] [Abstract][Full Text] [Related]
8. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of Chinese herbal injections combined with transcatheter hepatic arterial chemoembolization in treatment of liver cancer: a bayesian network Meta-analysis.
Zhang D; Wang K; Zheng J; Wu J; Duan X; Ni M; Liu S; Zhang B; Zhao Y
J Tradit Chin Med; 2020 Apr; 40(2):167-187. PubMed ID: 32242383
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter Arterial Chemoembolization Plus
Zhu ZX; Liao MH; Wang XX; Huang JW
Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.
Sun Q; Ma W; Gao Y; Zheng W; Zhang B; Peng Y
Afr J Tradit Complement Altern Med; 2012; 9(2):178-88. PubMed ID: 23983333
[TBL] [Abstract][Full Text] [Related]
12. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis.
Bai H; Gao P; Gao H; Sun G; Dong C; Han J; Jiang G
Med Sci Monit; 2016 May; 22():1773-81. PubMed ID: 27228411
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of Cinobufacini combined with transcatheterarterial chemoembolization in the treatment of advanced hepatocellular carcinoma.
Wu T; Sun R; Wang Z; Yang W; Shen S; Zhao Z
J Cancer Res Ther; 2014 Aug; 10 Suppl 1():60-4. PubMed ID: 25207894
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
[TBL] [Abstract][Full Text] [Related]
17. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Shu X; McCulloch M; Xiao H; Broffman M; Gao J
Integr Cancer Ther; 2005 Sep; 4(3):219-29. PubMed ID: 16113029
[TBL] [Abstract][Full Text] [Related]
18. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma.
Zhao H; Zhai X; Chen Z; Wan X; Chen L; Shen F; Ling C
Oncotarget; 2017 Jul; 8(28):45234-45241. PubMed ID: 28423370
[TBL] [Abstract][Full Text] [Related]
20. Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Meng MB; Cui YL; Guan YS; Ying Z; Zheng MH; Yuan CK; Zhang RM
J Altern Complement Med; 2008 Oct; 14(8):1027-42. PubMed ID: 18990050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
